Does BUPRENORPHINE Cause Injection site discolouration? 28 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Injection site discolouration have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.0% of all adverse event reports for BUPRENORPHINE.
28
Reports of Injection site discolouration with BUPRENORPHINE
0.0%
of all BUPRENORPHINE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site discolouration From BUPRENORPHINE?
Of the 28 reports, 3 (10.7%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does BUPRENORPHINE Cause?
Drug dependence (16,730)
Overdose (13,977)
Death (13,604)
Toxicity to various agents (10,906)
Pain (8,219)
Drug withdrawal syndrome (7,149)
Emotional distress (6,159)
Drug abuse (4,344)
Drug ineffective (4,261)
Dependence (3,184)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
Which BUPRENORPHINE Alternatives Have Lower Injection site discolouration Risk?
BUPRENORPHINE vs BUPRENORPHINE\NALOXONE
BUPRENORPHINE vs BUPROPION
BUPRENORPHINE vs BUPROPION HYDROBROMIDE
BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPRENORPHINE vs BUPROPION\NALTREXONE